AR011943A1 - Prediccion de enfermedades de la arteria coronaria - Google Patents
Prediccion de enfermedades de la arteria coronariaInfo
- Publication number
- AR011943A1 AR011943A1 ARP980101032A ARP980101032A AR011943A1 AR 011943 A1 AR011943 A1 AR 011943A1 AR P980101032 A ARP980101032 A AR P980101032A AR P980101032 A ARP980101032 A AR P980101032A AR 011943 A1 AR011943 A1 AR 011943A1
- Authority
- AR
- Argentina
- Prior art keywords
- coronary artery
- artery disease
- prediction
- diseases
- patient
- Prior art date
Links
- 210000004351 coronary vessel Anatomy 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 5
- 108700028369 Alleles Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/813,456 US6210877B1 (en) | 1997-03-10 | 1997-03-10 | Prediction of coronary artery disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011943A1 true AR011943A1 (es) | 2000-09-13 |
Family
ID=25212420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980101032A AR011943A1 (es) | 1997-03-10 | 1998-03-09 | Prediccion de enfermedades de la arteria coronaria |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6210877B1 (OSRAM) |
| EP (1) | EP0983381B1 (OSRAM) |
| JP (2) | JP4250765B2 (OSRAM) |
| CN (1) | CN100523214C (OSRAM) |
| AR (1) | AR011943A1 (OSRAM) |
| AT (1) | ATE370246T1 (OSRAM) |
| AU (1) | AU738875B2 (OSRAM) |
| BR (1) | BR9808313A (OSRAM) |
| CA (1) | CA2282746C (OSRAM) |
| DE (2) | DE69838250T2 (OSRAM) |
| DK (1) | DK0983381T3 (OSRAM) |
| EA (1) | EA199900813A1 (OSRAM) |
| ES (1) | ES2156843T3 (OSRAM) |
| GR (1) | GR20010300016T1 (OSRAM) |
| IL (1) | IL131745A0 (OSRAM) |
| MX (1) | MXPA99008223A (OSRAM) |
| NO (1) | NO994365L (OSRAM) |
| NZ (1) | NZ337642A (OSRAM) |
| PL (1) | PL335603A1 (OSRAM) |
| PT (1) | PT983381E (OSRAM) |
| WO (1) | WO1998040517A1 (OSRAM) |
| ZA (1) | ZA981937B (OSRAM) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6720141B1 (en) | 1999-11-01 | 2004-04-13 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for restenosis |
| US6524795B1 (en) * | 1997-03-10 | 2003-02-25 | Interleukin Genetics, Inc. | Diagnostics for cardiovascular disorders |
| US6210877B1 (en) * | 1997-03-10 | 2001-04-03 | Interleukin Genetics, Inc. | Prediction of coronary artery disease |
| US7820383B2 (en) | 1997-03-10 | 2010-10-26 | Interleukin Genetics, Inc. | Method for diagnosing myocardial infarction |
| GB9711040D0 (en) * | 1997-05-29 | 1997-07-23 | Duff Gordon W | Prediction of inflammatory disease |
| US20050282198A1 (en) * | 1997-05-29 | 2005-12-22 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype |
| GB9723835D0 (en) * | 1997-11-13 | 1998-01-07 | Nicklin Martin | Interleukin knockout |
| US6437216B1 (en) | 1997-11-13 | 2002-08-20 | Interleukin Genetics Inc. | Transgenic models of inflammatory disease |
| US6746839B1 (en) * | 1998-01-12 | 2004-06-08 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for an obstructive airway disease |
| US20050032077A1 (en) * | 1998-03-10 | 2005-02-10 | Duff Gordon W. | Detecting genetic predisposition to sight-threatening diabetic retinopathy |
| AU769949B2 (en) * | 1998-04-21 | 2004-02-12 | Interleukin Genetics, Inc. | Fetal testing for prediction of low birth weight |
| US6733967B1 (en) | 1998-04-21 | 2004-05-11 | Interleukin Genetics, Inc. | Fetal testing for prediction of low birth weight |
| US6251598B1 (en) | 1998-10-30 | 2001-06-26 | Interleukin Genetics, Inc. | Methods for diagnosing sepsis |
| JP2003500005A (ja) * | 1999-02-10 | 2003-01-07 | インターリューキン ジェネティックス インコーポレイテッド | ＩＬ−１β遺伝子の突然変異に基づく治療および診断 |
| JP2003500069A (ja) * | 1999-05-24 | 2003-01-07 | インタールーキン ジェネティックス インク | 再狭窄の診断及び治療薬 |
| IL147182A0 (en) * | 1999-06-30 | 2002-08-14 | Interleukin Genetics Inc | Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplorype |
| EP1409737A4 (en) * | 2001-06-15 | 2005-10-12 | Interleukin Genetics Inc | METHODS OF DETECTING AND TREATING EARLY APPEARANCE OF CONDITIONS RELATED TO AGING |
| US20080311581A1 (en) * | 2001-11-19 | 2008-12-18 | David Wyllie | Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases |
| CN1753903B (zh) | 2001-11-19 | 2010-05-12 | 白介素遗传公司 | 影响转录和对炎性和传染性疾病的敏感性的白细胞介素-1基因座的功能多态性 |
| EP1327639A1 (en) * | 2002-01-15 | 2003-07-16 | Bayer Ag | Prediction of cardiovascular disease by genetic polymorphisms in cardiovascular associated genes |
| KR100924468B1 (ko) * | 2002-01-25 | 2009-11-03 | 인터레우킨 제네틱스, 인코포레이티드 | Ｉｌ-1 유전자 집단 및 관련된 염증성 다형성과 일배체형 |
| US20070264645A1 (en) * | 2002-01-25 | 2007-11-15 | Kenneth Kornman | IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| WO2004029618A2 (en) * | 2002-09-30 | 2004-04-08 | Novartis Ag | Methods to predict cholesterol elevations during immunosuppressant therapy |
| US20050053956A1 (en) * | 2002-11-13 | 2005-03-10 | Dietz Harry C. | Detection of a predisposition for the development of coronary artery disease |
| WO2004069867A2 (en) * | 2003-02-03 | 2004-08-19 | Bayer Healthcare Ag | Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| US7625699B2 (en) * | 2003-03-10 | 2009-12-01 | Celera Corporation | Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof |
| EP1753875A2 (en) * | 2004-05-07 | 2007-02-21 | Applera Corporation | Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof |
| US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| US8105775B2 (en) * | 2005-10-25 | 2012-01-31 | Interleukin Genetics, Inc. | IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| RU2310862C1 (ru) * | 2006-05-02 | 2007-11-20 | Государственное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" | Способ выявления риска развития ишемической болезни сердца |
| US7935498B2 (en) * | 2006-07-07 | 2011-05-03 | Siemens Healthcare Diagnostics Inc. | Methods for identifying patients with increased risk of an adverse cardiovascular event |
| ES2431671T3 (es) * | 2006-11-15 | 2013-11-27 | Interleukin Genetics, Inc. | El complejo génico de IL-1 y resistencia a la insulina: polimorfismos asociados, haplotipos y métodos para usarlos |
| JP2011502510A (ja) * | 2007-11-08 | 2011-01-27 | インタールーキン ジェネティクス， インコーポレイテッド | 老化に関係がある皮膚疾患の診断 |
| US20100112570A1 (en) * | 2008-10-22 | 2010-05-06 | Interleukin Genetics, Inc. | Genetic Markers for Weight Management and Methods of Use Thereof |
| CN102747075B (zh) * | 2012-06-07 | 2014-07-23 | 中国医学科学院阜外心血管病医院 | 与冠心病相关的6号染色体易感区域标签单核苷酸多态性位点及其组成的单体型与应用 |
| JP2019503176A (ja) | 2016-01-12 | 2019-02-07 | インターロイキン ジェネティクス， インコーポレイテッド | 処置に対する応答を予測するための方法 |
| CN106202936A (zh) * | 2016-07-13 | 2016-12-07 | 为朔医学数据科技（北京）有限公司 | 一种疾病风险预测方法及系统 |
| US10337070B2 (en) | 2017-01-12 | 2019-07-02 | Cardioforecast Ltd. | Methods and kits for treating cardiovascular disease |
| CA3142662A1 (en) | 2019-06-06 | 2020-12-10 | Sitokine Limited | Compositions and methods for treating lung, colorectal and breast cancer |
| CN110277137B (zh) * | 2019-06-13 | 2022-03-18 | 南方医科大学顺德医院(佛山市顺德区第一人民医院) | 一种用于检测冠心病的基因芯片信息处理系统及方法 |
| WO2021028469A1 (en) | 2019-08-12 | 2021-02-18 | Sitokine Limited | Compositions and methods for treating cytokine release syndrome and neurotoxicity |
| WO2021205013A1 (en) | 2020-04-09 | 2021-10-14 | Sitokine Limited | Compositions and methods for treating covid-19 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4582788A (en) | 1982-01-22 | 1986-04-15 | Cetus Corporation | HLA typing method and cDNA probes used therein |
| US5110920A (en) | 1982-01-22 | 1992-05-05 | Cetus Corporation | HLA typing method and DNA probes used therein |
| US4623619A (en) | 1982-03-03 | 1986-11-18 | Nordisk Insulinlaboratorium | Method for the determination of liability in human individuals to develop atherosclerosis |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5268267A (en) | 1987-08-21 | 1993-12-07 | The General Hospital Corporation | Method for diagnosing small cell carcinoma |
| GB9301453D0 (en) * | 1993-01-26 | 1993-03-17 | Clonit Spa | Nucleotide proves |
| US5658729A (en) | 1994-10-11 | 1997-08-19 | The University Of British Columbia | Method, reagent and kit for evaluating susceptibility to premature atherosclerosis |
| US5686246A (en) | 1995-08-03 | 1997-11-11 | Kornman; Kenneth S. | Detecting genetic predisposition to periodontal disease |
| US5698399A (en) | 1996-04-05 | 1997-12-16 | Duff; Gordon W. | Detecting genetic predisposition for osteoporosis |
| US6210877B1 (en) * | 1997-03-10 | 2001-04-03 | Interleukin Genetics, Inc. | Prediction of coronary artery disease |
-
1997
- 1997-03-10 US US08/813,456 patent/US6210877B1/en not_active Expired - Fee Related
-
1998
- 1998-03-06 ZA ZA9801937A patent/ZA981937B/xx unknown
- 1998-03-09 PT PT98910298T patent/PT983381E/pt unknown
- 1998-03-09 AR ARP980101032A patent/AR011943A1/es unknown
- 1998-03-09 MX MXPA99008223A patent/MXPA99008223A/es unknown
- 1998-03-09 AT AT98910298T patent/ATE370246T1/de not_active IP Right Cessation
- 1998-03-09 NZ NZ337642A patent/NZ337642A/en unknown
- 1998-03-09 DE DE69838250T patent/DE69838250T2/de not_active Expired - Lifetime
- 1998-03-09 DK DK98910298T patent/DK0983381T3/da active
- 1998-03-09 ES ES98910298T patent/ES2156843T3/es not_active Expired - Lifetime
- 1998-03-09 EA EA199900813A patent/EA199900813A1/ru unknown
- 1998-03-09 WO PCT/US1998/004725 patent/WO1998040517A1/en not_active Ceased
- 1998-03-09 EP EP98910298A patent/EP0983381B1/en not_active Expired - Lifetime
- 1998-03-09 IL IL13174598A patent/IL131745A0/xx unknown
- 1998-03-09 BR BR9808313-9A patent/BR9808313A/pt not_active Application Discontinuation
- 1998-03-09 CA CA002282746A patent/CA2282746C/en not_active Expired - Fee Related
- 1998-03-09 JP JP53974098A patent/JP4250765B2/ja not_active Expired - Fee Related
- 1998-03-09 CN CNB988049155A patent/CN100523214C/zh not_active Expired - Fee Related
- 1998-03-09 AU AU64574/98A patent/AU738875B2/en not_active Ceased
- 1998-03-09 DE DE0983381T patent/DE983381T1/de active Pending
- 1998-03-09 PL PL98335603A patent/PL335603A1/xx unknown
-
1999
- 1999-09-09 NO NO994365A patent/NO994365L/no unknown
-
2001
- 2001-04-30 GR GR20010300016T patent/GR20010300016T1/el unknown
-
2008
- 2008-10-29 JP JP2008277752A patent/JP2009077727A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001514522A (ja) | 2001-09-11 |
| MXPA99008223A (es) | 2003-07-21 |
| NO994365D0 (no) | 1999-09-09 |
| DK0983381T3 (da) | 2007-12-17 |
| PL335603A1 (en) | 2000-05-08 |
| EP0983381A1 (en) | 2000-03-08 |
| DE69838250D1 (de) | 2007-09-27 |
| CN1255948A (zh) | 2000-06-07 |
| US6210877B1 (en) | 2001-04-03 |
| CA2282746C (en) | 2009-02-24 |
| JP2009077727A (ja) | 2009-04-16 |
| ES2156843T3 (es) | 2008-04-16 |
| DE69838250T2 (de) | 2008-05-08 |
| AU6457498A (en) | 1998-09-29 |
| DE983381T1 (de) | 2000-11-09 |
| GR20010300016T1 (en) | 2001-04-30 |
| CN100523214C (zh) | 2009-08-05 |
| PT983381E (pt) | 2007-11-26 |
| ATE370246T1 (de) | 2007-09-15 |
| EP0983381A4 (en) | 2004-05-12 |
| BR9808313A (pt) | 2000-05-16 |
| ES2156843T1 (es) | 2001-08-01 |
| AU738875B2 (en) | 2001-09-27 |
| NZ337642A (en) | 2001-02-23 |
| JP4250765B2 (ja) | 2009-04-08 |
| CA2282746A1 (en) | 1998-09-17 |
| WO1998040517A1 (en) | 1998-09-17 |
| ZA981937B (en) | 1999-09-06 |
| IL131745A0 (en) | 2001-03-19 |
| EA199900813A1 (ru) | 2000-06-26 |
| EP0983381B1 (en) | 2007-08-15 |
| NO994365L (no) | 1999-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9808313A (pt) | Métodos para determinar a predisposição de um paciente à doença arterial coronariana e kit para previsão de doença arterial coronariana | |
| Castanares-Zapatero et al. | Pathophysiology and mechanism of long COVID: a comprehensive review | |
| König et al. | Fully automatic speech-based analysis of the semantic verbal fluency task | |
| Barak et al. | PPIL4 is essential for brain angiogenesis and implicated in intracranial aneurysms in humans | |
| EA199901097A1 (ru) | Прогнозирование воспалительного заболевания, ассоциированного с полиморфизмом генных локусов il-1 | |
| Draus-Barini et al. | Bona fide colour: DNA prediction of human eye and hair colour from ancient and contemporary skeletal remains | |
| Kenworthy et al. | Early language milestones predict later language, but not autism symptoms in higher functioning children with autism spectrum disorders | |
| DE60331941D1 (de) | Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert | |
| ES2175355T3 (es) | Composiciones y metodos para determinar la susceptibilidad y la resistencia a farmacos antivirales y rastreo de farmacos antivirales. | |
| EA200970781A1 (ru) | Варианты генетической предрасположенности, связанные с сердечно-сосудистыми заболеваниями | |
| CY1105322T1 (el) | Μεθοδοι και συνθεσεις για την ανιχνευση παθολογικων συμβαντων | |
| WO2006073682A3 (en) | Diagnostic test | |
| Frøjd et al. | Predictors of health-related quality of life in outpatients with coronary heart disease | |
| Dodson et al. | The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion | |
| Aslam et al. | Association of VPREB1 gene copy number variation and rheumatoid arthritis susceptibility | |
| Patel et al. | Normal prothrombin times in the presence of therapeutic levels of apixaban-in-vivo experience from King's College Hospital. | |
| Wilson et al. | Vein quality influences neointimal hyperplasia in an organ culture model of human saphenous vein | |
| Martínez-Valle et al. | Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies | |
| Sozer et al. | Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders | |
| Leo et al. | Strength training rescues mitochondrial dysfunction in skeletal muscle of patients with myotonic dystrophy type 1 | |
| Faress et al. | A systematic review of the possibility of determining age based on DNA methylation of the ELOVL2 gene in human samples | |
| Nguyen et al. | Acculturation strategies and severity of depression among Vietnamese migrants | |
| Rasmussen et al. | Associations between a new biomarker of elevated chronic inflammation and accelerated aging | |
| Rinaldi et al. | Depression in Indonesian Adults with Diabetes Mellitus: A Descriptive Study from The Population-Based Indonesia Family Life Survey (IFLS) | |
| Wang et al. | POS1384 DIFFERENT CLINICAL CHARACTERISTICS OF IGG4-RRD PATIENTS AND NON-IGG4-RRD PATIENTS: A LARGE CHINESE COHORT STUDY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |